重症急性胰腺炎外科干预方案的探讨  

Clinical Exploration of Surgical Intervention Protocols for Severe Acute Pancreatitis

作　　者：王代宏[1] 郑朝新[1] 王芳元[1] 余刚[1] 汪涛[1] 

机构地区：[1]咸宁学院附属第一医院外科,湖北咸宁437100

出　　处：《咸宁学院学报（医学版）》2007年第2期116-118,共3页Journal of Xianning Univarsity(medical Sciences)

摘　　要：目的探讨重症急性胰腺炎(SAP)外科干预的时机、指征与方式的选择。方法回顾性分析我院1997年5月至2005年12月收治的146例SAP病例,其中非手术治疗71例,早期外科干预治疗54例,中转外科干预治疗21例。结果本资料总治愈率86.3%,总死亡率13.7%,总并发症发生率45.2%。其中非手术组分别为88.7%、11.3%、36.6%;早期外科干预组为83.3%、16.7%、51.9%;中转外科干预组为85.7%、14.3%、57.1%。结论外科干预在治疗SAP中占有重要地位,应结合临床病理分期和病因选择外科干预的时机、指征和方式。Objective To explore the timing, indication and procedure of surgical intervention for severe acute pancreatitis（SAP）. Methods 146 cases with SAP treated in our hospital from May, 1997 to December, 2005 were analysed retrospectively. 71 cases received non-operative treatment and 54 cases received surgical intervention in early stage and 21 cases in late stage. Results The overall curative rate, mortality and rate of complication was respectively 86.3%, 13.7% and 45.2%. The curative rate, mortality and rate of complication in non-operative treatment group was respectively 88.7%, 11.3% and 36.6%, those in early surgical intervention group was respectively 83.3%, 16.7% and 51.9%. Conclusion Surgical intervention treatment plays an important role in SAP patients, we choosed the timing,indication and procedure of surgical intervention for severe acute pancreatitis integrating different clinico-pathological stage and pathogen.

关 键 词：胰腺炎 外科干预 

分 类 号：R657.51[医药卫生—外科学]